Christin Müller

1.4k total citations
35 papers, 1.0k citations indexed

About

Christin Müller is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Christin Müller has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 14 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Christin Müller's work include Influenza Virus Research Studies (10 papers), Viral gastroenteritis research and epidemiology (8 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Christin Müller is often cited by papers focused on Influenza Virus Research Studies (10 papers), Viral gastroenteritis research and epidemiology (8 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Christin Müller collaborates with scholars based in Germany, United States and Egypt. Christin Müller's co-authors include John Ziebuhr, Stephan Pleschka, Roland K. Hartmann, Arnold Grünweller, Kerstin Lange‐Grünweller, Martin Hardt, Ramakanth Madhugiri, Benjamin W. Neuman, Dominik Schwudke and Ahmed Mostafa and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Virology.

In The Last Decade

Christin Müller

35 papers receiving 1.0k citations

Peers

Christin Müller
Chonsaeng Kim South Korea
Bryan C. Mounce United States
Ana Shulla United States
Woo-Jin Shin United States
Zongyang Lv United States
Chonsaeng Kim South Korea
Christin Müller
Citations per year, relative to Christin Müller Christin Müller (= 1×) peers Chonsaeng Kim

Countries citing papers authored by Christin Müller

Since Specialization
Citations

This map shows the geographic impact of Christin Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christin Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christin Müller more than expected).

Fields of papers citing papers by Christin Müller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christin Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christin Müller. The network helps show where Christin Müller may publish in the future.

Co-authorship network of co-authors of Christin Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Christin Müller. A scholar is included among the top collaborators of Christin Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christin Müller. Christin Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Previti, Santo, Roberta Ettari, Christin Müller, et al.. (2024). Identification of Dual Inhibitors Targeting Main Protease (Mpro) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents. ACS Medicinal Chemistry Letters. 15(5). 602–609. 3 indexed citations
2.
Zandbergen, Ger van, Alois Fürstner, John Ziebuhr, et al.. (2024). Potent anti-coronaviral activity of pateamines and new insights into their mode of action. Heliyon. 10(13). e33409–e33409. 1 indexed citations
3.
Medrano, Francisco J., Sergio Martı́, Kemel Arafet, et al.. (2024). Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2. Communications Chemistry. 7(1). 15–15. 3 indexed citations
4.
Müller, Christin, et al.. (2023). Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone. Archives of Virology. 168(2). 63–63. 1 indexed citations
5.
Müller, Christin, et al.. (2023). Extracapsular extension of pN2 lymph node metastases is not prognostically significant in surgically resected patients with non-small cell lung cancer. Innovative Surgical Sciences. 8(1). 9–16. 1 indexed citations
6.
Previti, Santo, Roberta Ettari, Salvatore Di Maro, et al.. (2022). Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors. European Journal of Medicinal Chemistry. 247. 115021–115021. 18 indexed citations
7.
Müller, Christin, Axel Weber, Uwe Linne, et al.. (2021). Multi-level inhibition of coronavirus replication by chemical ER stress. Nature Communications. 12(1). 5536–5536. 70 indexed citations
8.
Schneider, Tim, Christin Müller, Lee-Hsueh Hung, et al.. (2021). Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs. Nucleic Acids Research. 49(21). 12502–12516. 43 indexed citations
9.
Müller, Christin, Nadja Karl, Hans‐Guido Wendel, et al.. (2021). The rocaglate CR-31-B (−) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo. Antiviral Research. 186. 105012–105012. 23 indexed citations
10.
Quernheim, Martin, Christin Müller, André Schreiber, et al.. (2020). Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model. Antiviral Research. 178. 104806–104806. 27 indexed citations
11.
Müller, Christin, Kerstin Lange‐Grünweller, Lisa Oestereich, et al.. (2020). Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol. Antiviral Research. 175. 104706–104706. 37 indexed citations
12.
Schultze, Tilman, Christin Müller, Helena Pillich, et al.. (2019). The secRNome of Listeria monocytogenes Harbors Small Noncoding RNAs That Are Potent Inducers of Beta Interferon. mBio. 10(5). 43 indexed citations
13.
Rappe, Julie C. F., Han Di, Christin Müller, et al.. (2018). Antiviral activity of K22 against members of the order Nidovirales. Virus Research. 246. 28–34. 15 indexed citations
14.
Müller, Christin, et al.. (2017). Ribonuclease fromBacillusActs as an Antiviral Agent against Negative- and Positive-Sense Single Stranded Human Respiratory RNA Viruses. BioMed Research International. 2017. 1–11. 18 indexed citations
15.
Haasbach, Emanuel, Christin Müller, Christina Ehrhardt, et al.. (2017). The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo. Antiviral Research. 142. 178–184. 46 indexed citations
16.
Müller, Christin, Kerstin Lange‐Grünweller, Ramakanth Madhugiri, et al.. (2017). Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses. Antiviral Research. 150. 123–129. 151 indexed citations
17.
Müller, Christin, Martin Hardt, Dominik Schwudke, et al.. (2017). Inhibition of Cytosolic Phospholipase A2α Impairs an Early Step of Coronavirus Replication in Cell Culture. Journal of Virology. 92(4). 97 indexed citations
18.
Biedenkopf, Nadine, Kerstin Lange‐Grünweller, Christin Müller, et al.. (2016). The natural compound silvestrol is a potent inhibitor of Ebola virus replication. Antiviral Research. 137. 76–81. 77 indexed citations
19.
Müller, Christin, et al.. (2016). A Novel Antiviral Strategy against MERS-CoV and HCoV-229E Using Binase to Target Viral Genome Replication. BioNanoScience. 7(2). 294–299. 19 indexed citations
20.
Zurbriggen, Andreas, et al.. (1994). Canine distemper virus and myelin mRNAs in oligodendrocytes.. PubMed. 145(3). 17–17. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026